Dianthus Therapeutics DNTH SEC Filings

NASDAQ DNTH
$107.64 -0.21 (-0.19%)
As of: Sep 4, 2026 · 12:45 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Dianthus Therapeutics, Inc. /DE/ (DNTH) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index